Earnings Feed
Start Free
EyePoint Pharmaceuticals, Inc.·4

Jan 7, 4:04 PM ET

ANDO GORAN 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 7, 2025

Insider Transaction Report

Form 4
Period: 2025-01-03
EyePoint Pharmaceuticals, Inc.EYPT
ANDO GORAN
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-03+41,500→ 41,500 total
    Exercise: $8.26From: 2026-01-03Exp: 2035-01-03→ Common Stock (41,500 underlying)

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT